The docket

Patent litigations.

6,606 cases tracked. Click any row for full case detail; use the buckets below to slice by patent, plaintiff, or defendant. Manage cases (upload CSV, edit, delete) in Admin.

Demand letter analyzer

You got a patent demand letter. Now what?

Paste the letter — we extract the asserted patents, identify the asserter, characterize their litigation history, flag validity vulnerabilities, and draft a sample response letter your attorney can review. Free, private, ~2-3 minutes.

Analyze a letter →

Patent litigation filed per year

1986: 2 cases'861988: 1 case1990: 1 case'901992: 1 case1993: 1 case'941996: 3 cases1997: 2 cases1998: 3 cases'981999: 3 cases2000: 3 cases2001: 5 cases'022003: 10 cases2004: 4 cases2005: 13 cases2006: 15 cases'062007: 17 cases2008: 20 cases2009: 12 cases2010: 39 cases'102011: 36 cases2012: 68 cases2013: 110 cases2014: 95 cases'142015: 107 cases2016: 103 cases2017: 163 cases2018: 171 cases'182019: 198 cases2020: 226 cases2021: 254 cases2022: 358 cases'222023: 321 cases2024: 548 cases2025: 758 cases7582026: 333 cases'26
6,606 tracked cases by filing year.

Analyze a patent

Drop a US patent number — we’ll verify it on Google Patents and generate the full invalidity dossier.

By industry

All litigations

CasePatentsCourtFiledStatus
Cigna Corp. v. Celgene Corp.2:21-cv-00090U.S. District Court for the Eastern District of Pennsylvania—active
The Cigna Group v. Celgene Corp.——unknown
Untitled case2:10-cv-05197——unknown
IPR2015-01103IPR2015-01103USPTO Patent Trial and Appeal Board—PTAB proceeding
Celgene Corp. v. Peter19-1074Supreme Court of the United States—cert. petition
In re Xyrem (Sodium Oxybate) Antitrust Litigation3:20-md-02966-RSN.D. Cal.—unknown
Untitled case2:10-cv-06108D.N.J.—unknown
Untitled case2:19-cv-13994D.N.J.—unverified
Celgene Corporation v. [party]2:07-cv-05485U.S. District Court for the District of New Jersey——
Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals, LLC2017-1675U.S. Court of Appeals for the Federal Circuit—affirmed
In re Xyrem (Sodium Oxybate) Antitrust LitigationU.S. District Court for the Northern District of California—ongoing; trial set May 19, 2025; settlements with Amneal and Lupin final approval April 17, 2024
Jazz Pharmaceuticals, Inc. v. Par Pharmaceutical, Inc.2017-1671U.S. Court of Appeals for the Federal Circuit—settled during appeal
Jazz Pharmaceuticals, Inc. v. Wockhardt Bio AG2:15-cv-5619U.S. District Court for the District of New Jersey—pending
Jazz Pharmaceuticals, Inc. v. Lupin Ltd.2:15-cv-6548U.S. District Court for the District of New Jersey—pending
Jazz Pharmaceuticals, Inc. v. Roxane Laboratories, Inc.2:10-cv-6108U.S. District Court for the District of New Jersey—pending
Jazz Pharmaceuticals, Inc. v. Watson Laboratories, Inc.2:14-cv-07757United States District Court for the District of New Jersey—consolidated
Untitled case2:15-cv-06548United States District Court for the District of New Jersey—unverified
Amneal Pharmaceuticals, LLC et al. v. Jazz Pharmaceuticals, Inc.CBM2014-00150Patent Trial and Appeal Board, U.S. Patent and Trademark Office—denied / not instituted
Jazz Pharmaceuticals, Inc. v. Par Pharmaceutical, Inc.2:13-cv-07884United States District Court for the District of New Jersey—settled
Jazz Pharmaceuticals, Inc. v. Wockhardt Bio AG2:14-cv-07757United States District Court for the District of New Jersey—related litigation